Search Results - "Bryant, Alexander P."
-
1
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
Published in European journal of pharmacology (15-12-2010)“…Linaclotide is a first-in-class, orally administered 14-amino acid peptide that is in development for the treatment of irritable bowel syndrome with…”
Get full text
Journal Article -
2
Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral pain
Published in Frontiers in molecular neuroscience (16-04-2014)“…Activation of guanylate cyclase-C (GC-C) expressed predominantly on intestinal epithelial cells by guanylin, uroguanylin or the closely related GC-C agonist…”
Get full text
Journal Article -
3
Inhibition of Filamentation Can Be Used To Treat Disseminated Candidiasis
Published in Antimicrobial Agents and Chemotherapy (01-10-2006)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
4
A genomic analysis of two‐component signal transduction in Streptococcus pneumoniae
Published in Molecular microbiology (01-02-2000)“…A genomics‐based approach was used to identify the entire gene complement of putative two‐component signal transduction systems (TCSTSs) in Streptococcus…”
Get full text
Journal Article -
5
Identification, Evolution, and Essentiality of the Mevalonate Pathway for Isopentenyl Diphosphate Biosynthesis in Gram-Positive Cocci
Published in Journal of Bacteriology (01-08-2000)“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
6
Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation
Published in The Journal of pharmacology and experimental therapeutics (01-01-2013)“…Linaclotide, a potent guanylate cyclase C agonist, is a therapeutic peptide approved in the United States for the treatment of irritable bowel syndrome with…”
Get more information
Journal Article -
7
The srhSR Gene Pair from Staphylococcus aureus: Genomic and Proteomic Approaches to the Identification and Characterization of Gene Function
Published in Biochemistry (Easton) (28-08-2001)“…Systematic analysis of the entire two-component signal transduction system (TCSTS) gene complement of Staphylococcus aureus revealed the presence of a putative…”
Get full text
Journal Article -
8
Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract
Published in Life sciences (1973) (08-05-2010)“…Linaclotide is an orally administered 14-amino acid peptide being developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and…”
Get full text
Journal Article -
9
MRP4 Modulation of the Guanylate Cyclase-C/cGMP Pathway: Effects on Linaclotide-Induced Electrolyte Secretion and cGMP Efflux
Published in The Journal of pharmacology and experimental therapeutics (01-10-2015)“…MRP4 mediates the efflux of cGMP and cAMP and acts as an important regulator of these secondary messengers, thereby affecting signaling events mediated by cGMP…”
Get more information
Journal Article -
10
Gastrointestinal pain: Unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation
Published in Pain (Amsterdam) (01-09-2013)“…Uroguanylin activation of the guanylate cyclase-C/cyclic guanosine monophosphate pathway elicits analgesic effects in animal models of colonic…”
Get full text
Journal Article -
11
Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus
Published in Journal of bacteriology (01-09-2000)“…Sequence comparisons have implied the presence of genes encoding enzymes of the mevalonate pathway for isopentenyl diphosphate biosynthesis in the…”
Get full text
Journal Article -
12
rho is not essential for viability or virulence in Staphylococcus aureus
Published in Antimicrobial agents and chemotherapy (01-04-2001)“…We have identified the gene for transcription termination factor Rho in Staphylococcus aureus. Deletion of rho in S. aureus reveals that it is not essential…”
Get full text
Journal Article -
13
The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulence
Published in Microbiology (Society for General Microbiology) (01-07-2000)“…Anti-Infective Research (UP1345), SmithKline Beecham Pharmaceuticals, 1250 South Collegeville Road, PO Box 5089, Collegeville, PA19426-0989, USA 1 Author for…”
Get full text
Journal Article -
14
-
15
-
16
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infection
Published in Microbiology (Society for General Microbiology) (01-02-2001)“…Anti-Infectives Research, SmithKline Beecham Pharmaceuticals Research and Development, 1250 S. Collegeville Road, Collegeville, PA 19426, USA 1 Department of…”
Get full text
Journal Article -
17
rho Is Not Essential for Viability or Virulence inStaphylococcus aureus
Published in Antimicrobial Agents and Chemotherapy (01-04-2001)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
18
A functional genomic analysis of type 3 Streptococcus pneumoniae virulence
Published in Molecular microbiology (01-05-2001)“…Streptococcus pneumoniae remains a serious cause of morbidity and mortality in humans, but relatively little is known about the molecular basis of its…”
Get full text
Journal Article -
19
Linaclotide Significantly Improves Post-Operative Ileus and Opiate-Induced Constipation in Rats: 1257
Published in The American journal of gastroenterology (01-09-2006)Get full text
Journal Article -
20
ANTINOCICEPTIVE ACTIONS OF MD-1100, A NOVEL THERAPEUTIC AGENT FOR c-IBS, IN ANIMAL MODELS OF VISCERAL PAIN: 867
Published in The American journal of gastroenterology (01-10-2004)Get full text
Journal Article